Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 5, 2025
Time-restricted eating to address persistent cancer-related fatigue among cancer survivors: a randomized controlled trialAmber S Kleckner, Carin L Clingan, Shari M Youngblood, et al.
Cancer|December 4, 2014
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center studyVishal Bhatnagar, Yin Wu, Olga G Goloubeva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myelomaWei-Gang Tong, Rong Chen, William Plunkett, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)Steven P Treon, Kirsten Meid, Christina Tripsas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
Blood Advances|July 11, 2019
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myelomaEdward A Stadtmauer, Thomas H Faitg, Daniel E Lowther, et al.
Ophthalmology and Therapy|July 27, 2020
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
Ophthalmology and Therapy|September 13, 2020
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 StudyAsim V Farooq, Simona Degli Esposti, Rakesh Popat, et al.
British Journal of Haematology|April 14, 2016
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assaySusan J Lee, Konstantin Levitsky, Francesco Parlati, et al.
Pageof 5